Cryoport, Inc. (CYRX)
16.38
-0.34
(-2.03%)
USD |
NASDAQ |
Aug 26, 12:47
Cryoport Enterprise Value : 728.44M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 728.44M |
| August 24, 2026 | 709.20M |
| August 21, 2026 | 749.21M |
| August 20, 2026 | 727.94M |
| August 19, 2026 | 707.68M |
| August 18, 2026 | 645.89M |
| August 17, 2026 | 657.54M |
| August 14, 2026 | 653.99M |
| August 13, 2026 | 647.91M |
| August 12, 2026 | 631.20M |
| August 11, 2026 | 638.80M |
| August 10, 2026 | 632.21M |
| August 07, 2026 | 647.41M |
| August 06, 2026 | 626.64M |
| August 05, 2026 | 653.99M |
| August 04, 2026 | 652.47M |
| August 03, 2026 | 666.15M |
| July 31, 2026 | 645.89M |
| July 30, 2026 | 658.04M |
| July 29, 2026 | 637.78M |
| July 28, 2026 | 649.94M |
| July 27, 2026 | 648.92M |
| July 24, 2026 | 660.07M |
| July 23, 2026 | 693.50M |
| July 22, 2026 | 713.25M |
| Date | Value |
|---|---|
| July 21, 2026 | 704.13M |
| July 20, 2026 | 677.29M |
| July 17, 2026 | 717.81M |
| July 16, 2026 | 716.79M |
| July 15, 2026 | 720.85M |
| July 14, 2026 | 695.52M |
| July 13, 2026 | 677.29M |
| July 10, 2026 | 700.59M |
| July 09, 2026 | 677.79M |
| July 08, 2026 | 654.50M |
| July 07, 2026 | 644.37M |
| July 06, 2026 | 652.98M |
| July 02, 2026 | 666.15M |
| July 01, 2026 | 684.89M |
| June 30, 2026 | 676.78M |
| June 29, 2026 | 688.35M |
| June 26, 2026 | 674.30M |
| June 25, 2026 | 668.27M |
| June 24, 2026 | 650.20M |
| June 23, 2026 | 612.05M |
| June 22, 2026 | 612.55M |
| June 18, 2026 | 624.60M |
| June 17, 2026 | 602.51M |
| June 16, 2026 | 609.54M |
| June 15, 2026 | 615.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 56.99B |
| Protect Pharmaceutical Corp. | 14.37M |
| Champions Oncology, Inc. | 69.01M |
| Medpace Holdings, Inc. | 16.74B |
| Charles River Laboratories International, Inc. | 17.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.255M |
| Revenue (Quarterly) | 48.97M |
| Total Expenses (Quarterly) | 57.23M |
| EPS Diluted (Quarterly) | -0.2033 |
| Gross Profit Margin (Quarterly) | 39.66% |
| Profit Margin (Quarterly) | -16.86% |
| Earnings Yield | -4.99% |
| Normalized Earnings Yield | -5.021 |